AYSE MINDIKOGLU

TitleAssociate Professor
InstitutionBaylor College of Medicine
DepartmentDepartment of Medicine
Address6620 MAIN
Houston, TX 77030
Email
vCardDownload vCard
    Other Positions
    TitleAssociate Professor
    InstitutionBaylor College of Medicine
    DepartmentDepartment of Surgery
    DivisionSurgery-Transplant Division


    Collapse Biography 
    Collapse awards and honors
    2010 - 20152010 Mentored Patient-Oriented Research Career Development Award (NIH/NIDDK K23)
    20042004 American Association for the Study of Liver Diseases Advanced Hepatology Fellowship Award

    Collapse Overview 

    Collapse Research 
    Collapse research activities and funding
    K23DK089008     (MINDIKOGLU, AYSE LEYLA)Jul 1, 2010 - Jun 30, 2015
    NIH/NIDDK
    Gender Disparity in Liver Transplantation
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Barbara M, Mindikoglu AL. The role of zinc in the prevention and treatment of nonalcoholic fatty liver disease. Metabol Open. 2021 Sep; 11:100105. PMID: 34337376.
      Citations:    
    2. Abdulsada MM, Wilhelm ZR, Opekun AR, Devaraj S, Jalal PK, Mindikoglu AL. The effect of four-week intermittent fasting from dawn to sunset on circulating brain-derived neurotrophic factor levels in subjects with metabolic syndrome and healthy subjects. Metabol Open. 2021 Mar; 9:100070. PMID: 33376976.
      Citations:    
    3. Mindikoglu AL, Abdulsada MM, Jain A, Jalal PK, Devaraj S, Wilhelm ZR, Opekun AR, Jung SY. Intermittent fasting from dawn to sunset for four consecutive weeks induces anticancer serum proteome response and improves metabolic syndrome. Sci Rep. 2020 10 27; 10(1):18341. PMID: 33110154.
      Citations: 2     Fields:    Translation:HumansCTClinical Trials
    4. Barbara M, Dhingra S, Mindikoglu AL. Drug-Induced Liver Injury Associated With Alpha Bolic (RAD-140) and Alpha Elite (RAD-140 and LGD-4033). ACG Case Rep J. 2020 Jun; 7(6):e00409. PMID: 33062783.
      Citations: 1     
    5. Barbara M, Dhingra S, Mindikoglu AL. Ligandrol (LGD-4033)-Induced Liver Injury. ACG Case Rep J. 2020 Jun; 7(6):e00370. PMID: 32637435.
      Citations: 2     
    6. Godfrey EL, Malik TH, Lai JC, Mindikoglu AL, Galván NTN, Cotton RT, O'Mahony CA, Goss JA, Rana A. Response to "Reply to: 'The decreasing predictive power of MELD in an era of changing etiology of liver disease'". Am J Transplant. 2020 03; 20(3):903-904. PMID: 31943742.
      Citations:    Fields:    Translation:Humans
    7. Mindikoglu AL, Abdulsada MM, Jain A, Choi JM, Jalal PK, Devaraj S, Mezzari MP, Petrosino JF, Opekun AR, Jung SY. Intermittent fasting from dawn to sunset for 30 consecutive days is associated with anticancer proteomic signature and upregulates key regulatory proteins of glucose and lipid metabolism, circadian clock, DNA repair, cytoskeleton remodeling, immune system and cognitive function in healthy subjects. J Proteomics. 2020 04 15; 217:103645. PMID: 31927066.
      Citations: 8     Fields:    Translation:HumansAnimalsCells
    8. Mindikoglu AL, Hernaez R, Liu Y, Kramer JR, Taylor T, Rana A, Kanwal F. Renal Trajectory Patterns Are Associated With Postdischarge Mortality in Patients With Cirrhosis and Acute Kidney Injury. Clin Gastroenterol Hepatol. 2020 07; 18(8):1858-1866.e6. PMID: 31778807.
      Citations: 2     Fields:    Translation:Humans
    9. Rana A, Ackah RL, Webb GJ, Halazun KJ, Vierling JM, Liu H, Wu MF, Yoeli D, Kueht M, Mindikoglu AL, Sussman NL, Galván NT, Cotton RT, O'Mahony CA, Goss JA. No Gains in Long-term Survival After Liver Transplantation Over the Past Three Decades. Ann Surg. 2019 01; 269(1):20-27. PMID: 29303806.
      Citations: 12     Fields:    Translation:Humans
    10. Khan V, Putluri N, Sreekumar A, Mindikoglu AL. Current Applications of Metabolomics in Cirrhosis. Metabolites. 2018 Oct 22; 8(4). PMID: 30360420.
      Citations: 2     
    11. Rana A, Sigireddi RR, Halazun KJ, Kothare A, Wu MF, Liu H, Kueht ML, Vierling JM, Sussman NL, Mindikoglu AL, Miloh T, Galvan NTN, Cotton RT, O'Mahony CA, Goss JA. Predicting Liver Allograft Discard: The Discard Risk Index. Transplantation. 2018 09; 102(9):1520-1529. PMID: 29485514.
      Citations: 4     Fields:    Translation:Humans
    12. Mindikoglu AL, Opekun AR, Mitch WE, Magder LS, Christenson RH, Dowling TC, Weir MR, Seliger SL, Howell CD, Raufman JP, Rana A, Goss JA, Khaderi SA, Vierling JM. Cystatin C Is a Gender-Neutral Glomerular Filtration Rate Biomarker in Patients with Cirrhosis. Dig Dis Sci. 2018 03; 63(3):665-675. PMID: 29392554.
      Citations: 7     Fields:    Translation:Humans
    13. Mindikoglu AL, Opekun AR, Putluri N, Devaraj S, Sheikh-Hamad D, Vierling JM, Goss JA, Rana A, Sood GK, Jalal PK, Inker LA, Mohney RP, Tighiouart H, Christenson RH, Dowling TC, Weir MR, Seliger SL, Hutson WR, Howell CD, Raufman JP, Magder LS, Coarfa C. Unique metabolomic signature associated with hepatorenal dysfunction and mortality in cirrhosis. Transl Res. 2018 05; 195:25-47. PMID: 29291380.
      Citations: 8     Fields:    Translation:Humans
    14. Mindikoglu AL, Opekun AR, Gagan SK, Devaraj S. Impact of Time-Restricted Feeding and Dawn-to-Sunset Fasting on Circadian Rhythm, Obesity, Metabolic Syndrome, and Nonalcoholic Fatty Liver Disease. Gastroenterol Res Pract. 2017; 2017:3932491. PMID: 29348746.
      Citations: 10     
    15. Rana A, Witte ED, Halazun KJ, Sood GK, Mindikoglu AL, Sussman NL, Vierling JM, Kueht ML, Galvan NTN, Cotton RT, O'Mahony CA, Goss JA. Liver transplant length of stay (LOS) index: A novel predictive score for hospital length of stay following liver transplantation. Clin Transplant. 2017 Dec; 31(12). PMID: 29044759.
      Citations: 4     Fields:    Translation:Humans
    16. Mindikoglu AL, Pappas SC. New Developments in Hepatorenal Syndrome. Clin Gastroenterol Hepatol. 2018 02; 16(2):162-177.e1. PMID: 28602971.
      Citations: 13     Fields:    Translation:Humans
    17. Goss M, Reese J, Kueht M, Vierling JM, Mindikoglu AL, Sussman NL, Kaplan B, Wood RP, Rana AA. A Surge in cadaveric liver donors and a national narcotic epidemic: Is there an association? Liver Transpl. 2017 05; 23(5):698-700. PMID: 28295986.
      Citations: 3     Fields:    Translation:Humans
    18. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 29551736.
      Citations: 1     Fields:    Translation:Humans
    19. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 31394020.
      Citations: 7     Fields:    Translation:Humans
    20. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 32025330.
      Citations:    
    21. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 26143343.
      Citations:    Fields:    Translation:Humans
    22. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 25763790.
      Citations: 3     Fields:    Translation:Humans
    23. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 23744636.
      Citations: 33     Fields:    Translation:Humans
    24. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 22299756.
      Citations: 5     Fields:    Translation:Humans
    25. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 21911144.
      Citations: 12     Fields:    Translation:Humans
    26. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 19562705.
      Citations: 21     Fields:    Translation:Humans
    27. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 16181390.
      Citations: 3     Fields:    Translation:HumansCells
    28. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 16861051.
      Citations: 34     Fields:    Translation:HumansCells
    29. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 16797327.
      Citations: 2     Fields:    Translation:Humans
    30. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 15830291.
      Citations: 2     Fields:    Translation:Humans
    31. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 15492908.
      Citations: 2     Fields:    Translation:Humans
    32. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 12823599.
      Citations: 1     Fields:    Translation:Humans
    33. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 12822875.
      Citations: 1     Fields:    Translation:Humans
    34. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 12628903.
      Citations: 1     Fields:    Translation:Humans
    35. Urrunaga NH, Magder LS, Weir MR, Rockey DC, Mindikoglu AL. Prevalence, Severity, and Impact of Renal Dysfunction in Acute Liver Failure on the US Liver Transplant Waiting List. Dig Dis Sci. 2016 Jan; 61(1):309-16. PMID: 26386861.
      Citations: 5     Fields:    Translation:Humans
    36. Mindikoglu AL, Dowling TC, Magder LS, Christenson RH, Weir MR, Seliger SL, Hutson WR, Howell CD. Estimation of Glomerular Filtration Rate in Patients With Cirrhosis by Using New and Conventional Filtration Markers and Dimethylarginines. Clin Gastroenterol Hepatol. 2016 Apr; 14(4):624-632.e2. PMID: 26133903.
      Citations: 6     Fields:    Translation:Humans
    37. Mindikoglu AL, Dowling TC, Wong-You-Cheong JJ, Christenson RH, Magder LS, Hutson WR, Seliger SL, Weir MR. A pilot study to evaluate renal hemodynamics in cirrhosis by simultaneous glomerular filtration rate, renal plasma flow, renal resistive indices and biomarkers measurements. Am J Nephrol. 2014; 39(6):543-52. PMID: 24943131.
      Citations: 8     Fields:    Translation:Humans
    38. Reddy SK, Reilly C, Zhan M, Mindikoglu AL, Jiang Y, Lane BF, Alexander HR, Culpepper WJ, El-Kamary SS. Long-term influence of chemotherapy on steatosis-associated advanced hepatic fibrosis. Med Oncol. 2014 Jun; 31(6):971. PMID: 24798875.
      Citations: 3     Fields:    Translation:Humans
    39. Urrunaga NH, Rachakonda VP, Magder LS, Mindikoglu AL. Outcomes of living versus deceased donor liver transplantation for acute liver failure in the United States. Transplant Proc. 2014 Jan-Feb; 46(1):219-24. PMID: 24507055.
      Citations: 7     Fields:    Translation:Humans
    40. Mindikoglu AL, Weir MR. Current concepts in the diagnosis and classification of renal dysfunction in cirrhosis. Am J Nephrol. 2013; 38(4):345-54. PMID: 24107793.
      Citations: 12     Fields:    Translation:Humans
    41. Mindikoglu AL, Emre SH, Magder LS. Impact of estimated liver volume and liver weight on gender disparity in liver transplantation. Liver Transpl. 2013 Jan; 19(1):89-95. PMID: 23008117.
      Citations: 16     Fields:    Translation:Humans
    42. Weinstein DH, Twaddell WS, Raufman JP, Philosophe B, Mindikoglu AL. SlimQuick™ - associated hepatotoxicity in a woman with alpha-1 antitrypsin heterozygosity. World J Hepatol. 2012 Apr 27; 4(4):154-7. PMID: 22567188.
      Citations: 8     
    43. Aslinia FM, Wasan SK, Mindikoglu AL, Adeyemo OA, Philosophe B, Drachenberg C, Howell CD. End-stage renal disease and African American race are independent predictors of mild liver fibrosis in patients with chronic hepatitis C infection. J Viral Hepat. 2012 May; 19(5):371-6. PMID: 22497817.
      Citations: 2     Fields:    Translation:Humans
    44. Mindikoglu AL, King D, Magder LS, Ozolek JA, Mazariegos GV, Shneider BL. Valproic acid-associated acute liver failure in children: case report and analysis of liver transplantation outcomes in the United States. J Pediatr. 2011 May; 158(5):802-7. PMID: 21167499.
      Citations: 5     Fields:    Translation:Humans
    45. Mindikoglu AL, Regev A, Seliger SL, Magder LS. Gender disparity in liver transplant waiting-list mortality: the importance of kidney function. Liver Transpl. 2010 Oct; 16(10):1147-57. PMID: 20879013.
      Citations: 26     Fields:    Translation:Humans
    46. Bhagat V, Mindikoglu AL, Nudo CG, Schiff ER, Tzakis A, Regev A. Outcomes of liver transplantation in patients with cirrhosis due to nonalcoholic steatohepatitis versus patients with cirrhosis due to alcoholic liver disease. Liver Transpl. 2009 Dec; 15(12):1814-20. PMID: 19938128.
      Citations: 44     Fields:    Translation:Humans
    47. Aslinia F, Mindikoglu AL. Radiofrequency ablation in patients with hepatocellular carcinoma. Hepatology. 2009 Dec; 50(6):2053; author reply 2053-4. PMID: 19937694.
      Citations:    Fields:    Translation:Humans
    48. Mindikoglu AL, Miller RR. Hepatitis C in the elderly: epidemiology, natural history, and treatment. Clin Gastroenterol Hepatol. 2009 Feb; 7(2):128-34; quiz 124. PMID: 19084480.
      Citations: 6     Fields:    Translation:Humans
    49. Mindikoglu AL, Regev A, Magder LS. Impact of human immunodeficiency virus on survival after liver transplantation: analysis of United Network for Organ Sharing database. Transplantation. 2008 Feb 15; 85(3):359-68. PMID: 18301332.
      Citations: 19     Fields:    Translation:HumansCells
    50. Mindikoglu AL, Regev A, Bejarano PA, Martinez EJ, Jeffers LJ, Schiff ER. Imatinib mesylate (gleevec) hepatotoxicity. Dig Dis Sci. 2007 Feb; 52(2):598-601. PMID: 17219077.
      Citations: 4     Fields:    Translation:Humans
    51. Mindikoglu AL, Li SD, Yong SL, Borge MA, Brems J, Van Thiel DH. HELLP syndrome complicated bile duct injury and subsequent left hepatic lobe atrophy. Dig Dis Sci. 2006 Jul; 51(7):1206-12. PMID: 16944011.
      Citations: 1     Fields:    Translation:Humans
    52. Mindikoglu AL, Regev A, Schiff ER. Epithelioid hemangioendothelioma of the liver. Clin Gastroenterol Hepatol. 2005 Jul; 3(7):xxxii. PMID: 16206490.
      Citations:    Fields:    Translation:Humans
    53. Bayraktar Y, Mindikoglu AL, Van Thiel DH. Postoperative infections in cirrhotic patients. Hepatogastroenterology. 2005 Jul-Aug; 52(64):1240-3. PMID: 16001671.
      Citations:    Fields:    Translation:Humans
    54. Mindikoglu AL, Regev A, Levi JU, Casillas J, Schiff ER. Focal nodular hyperplasia in identical twins. Am J Gastroenterol. 2005 Jul; 100(7):1616-9. PMID: 15984990.
      Citations: 2     Fields:    Translation:Humans
    55. Van Thiel DH, Farr DE, Mindikoglu AL, Todo A, George MM. Recombinant human factor VIIa-induced alterations in tissue factor and thrombomodulin in patients with advanced liver cirrhosis. J Gastroenterol Hepatol. 2005 Jun; 20(6):882-9. PMID: 15946135.
      Citations: 2     Fields:    Translation:Humans
    56. George MM, Li SD, Mindikoglu AL, Baluch MH, Dhillon S, Farr D, Van Thiel DH. Platelet sparing effect of COX II inhibition used with pegylated interferon alfa-2a for the treatment of chronic hepatitis C: a short term pilot study. Cytokine. 2004 Sep 21; 27(6):159-65. PMID: 15304245.
      Citations: 2     Fields:    Translation:HumansCells
    57. Van Thiel DH, George M, Mindikoglu AL, Baluch MH, Dhillon S. Coagulation and fibrinolysis in individuals with advanced liver disease. Turk J Gastroenterol. 2004 Jun; 15(2):67-72. PMID: 15334312.
      Citations: 2     Fields:    Translation:HumansCells
    58. Mindikoglu AL, Anantharaju A, George M, Leone N, Bejna J, Van Thiel DH. Splenic embolization in a Jehovah's Witness: role of recombinant human factor VIIa. Hepatogastroenterology. 2003 Sep-Oct; 50(53):1697-9. PMID: 14571820.
      Citations: 2     Fields:    Translation:Humans
    59. Mindikoglu AL, Anantharaju A, Hartman GG, Li SD, Villanueva J, Van Thiel DH. Prochlorperazine-induced cholestasis in a patient with alpha-1 antitrypsin deficiency. Hepatogastroenterology. 2003 Sep-Oct; 50(53):1338-40. PMID: 14571732.
      Citations: 1     Fields:    Translation:Humans
    60. Anantharaju A, Mehta K, Mindikoglu AL, Van Thiel DH. Use of activated recombinant human factor VII (rhFVIIa) for colonic polypectomies in patients with cirrhosis and coagulopathy. Dig Dis Sci. 2003 Jul; 48(7):1414-24. PMID: 12870806.
      Citations: 4     Fields:    Translation:Humans
    MINDIKOGLU's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (281)
    Explore
    _
    Co-Authors (22)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _